“Nova” means “new” in Latin. And the Novavax Covid-19 vaccine that just received Emergency Use Authorization (EUA) through the U. S. Food and Drug Administration. The U. S. Food and Drug Administration (FDA) is new. This is new because it is not completely new. And that can make a significant difference.
The FDA announced the EUA on July 13, after the FDA’s independent advisory committee on vaccines and similar biologics voted in favor of the authorization last week, on June 7. The EUA covers people over the age of 18. So if you can get a Costco card or punch or get tattooed, you can get the Novavax Covid-19 vaccine. Novavax vaccine now joins Pfizer/BioNTech, Moderna and Johnson
The Novavax Covid-18 vaccine, which has the industry’s so-called “Nuvaxovid” compatible with Scrabble, has been approved as a number one series of two doses for 3 weeks, or with only two Scaramuccis apart. Nuvaxovid had already obtained permission for use in the European Union in December 2021 and in Japan in April. Therefore, this vaccine is absolutely not new in the world and the United States will not be the first country to use it.
The FDA based its approval largely on the effects of an ongoing randomized, blinded, placebo-controlled study of approximately 17,000 adults in the U. S. Covid-19 in vaccine organization compared to 79 cases in placebo organization, suggesting that the vaccine was 90. 4% effective in preventing mild, moderate, or severe Covid-19. In other people over the age of 65, the measured effectiveness was less than 78. 6%. It should be noted that those effects of clinical trials came before the delta and omicron variants of the Covid-19 coronavirus came into play. So, take the power figures with a Ugg boot full of salt.
The trial did not raise any really broad protective considerations relative to the Novavax vaccine. The maximum side effects reported were similar to the side effects seen with other COVID-19 vaccines, such as inflammation at the injection site (p. e. g. , pain/tenderness, redness and swelling) and general constitutional symptoms (such as fatigue, muscle aches, headache, joint pain, nausea/vomiting, and fever). , which is an inflammation of the muscles of its center, and pericarditis, which is an inflammation of the membrane surrounding its center like Saran Wrap and Easter Bunny Chocolate. But the threat of those vaccine situations appears to be much, much less than the threat of contracting myocarditis or pericarditis while inflamed with the Covid-19 coronavirus.
While other COVID-19 vaccines may have gained more fanfare in the U. S. When they were first launched in late 2020 and early 2021, this new “new” vaccine remains the same. On the contrary, it is different in several key aspects:
As you may have already heard, the Pfizer-BioNTech and Moderna Covid-19 vaccines consist of mRNAs encapsulated in lipoprotein envelopes. These mRNAs serve as models for your cells to produce the complex protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV). -2). These spike proteins nail the surface of the virus, making it look like a bristly massage ball or at the end of one of those BDSM masses your roommate discovered in your closet. Similarly, the J vaccine
Keep in mind that those vaccines don’t fit your DNA, as other people and anonymous anti-vaccine social media accounts have claimed. They may not make him expand more arms, become a sheep, or suddenly like Justin Bieber’s song “Baby. “Again, they only provide blueprints for your cells to produce the spike protein for a limited time so that your immune formula can see the spike proteins and react to the spike, so to speak.
While researchers have been using those technologies for years, it’s true that the Pfizer-BioNTech and Moderna Covid-19 vaccines were the first time such mRNA approaches got EUA (and upcoming approvals) from the FDA. The J Vaccine Approach
The same can be said of Novavax. La Novavax Covid-19 vaccine includes a mixture of the true sars-CoV-2 spike protein and the so-called Matrix-M adjuvant. Novavax uses insect cells to produce the vaccine’s spike protein. The inclusion of the actual protein of a virus is a technique that has long been used for other vaccines, such as hepatitis B and pertussis vaccines. Matrix-M is not a film sequel starring Keanu Reeves and M’s
Unlike the more fragile mRNA, the parts of the Novavax Covid-19 vaccine are more durable. Therefore, popular refrigeration is possibly sufficient than the ultra-cold situations required for the Pfizer/BioNTech and Moderna Covid-19 vaccines. This can greatly facilitate the transportation, garage and management of the Novavax Covid-19 vaccine. This can help you succeed in places that don’t have the resources to house special freezers.
This may be another case where others are good. I covered for Forbes in December 2021 the potential advantages of combining and combining other types of vaccines for their number one Covid-19 vaccine series and enhancements. A heterologous improvement is when the type of seasoning is different from the type of vaccine used in the first series. By exposing your immune formula to SARS-CoV-2 in other ways, you can spice up your immune response, as can dating other types of people. This assumes you don’t need an idiot or a Harley Quinn. While Pfizer/BioNTech and Moderna basically differ in the amount of mRNA they involve and the mRNA vaccine differs from the J vaccine.
So far, the FDA has only legalized the number one series of the Novavax Covid-19 vaccine and not vaccine boosters. However, it’s no surprise that Novavax has discussed with the FDA the use of its vaccine as a booster for other types of Covid-19. Vaccines. Authorizing this retirement option would offer even more possibilities for heterologous retirement. Therefore, it may not be long before the Novavax Covid-19 vaccine can give it a boost.
In the end, the arrival of Novavax is potentially very smart news. Not only can this help vaccinate more people, but it can also serve as a heterologous booster option. It is a reminder that there are more vaccines against covid-19. It is also needed. Research and progress of new covid-19 vaccines are not slowed down or prevented just because there are already covid-19 vaccines on the market. As with maximum products, the variety and festival are smart, leading to more innovation and better products. After all, you wouldn’t tell every brand to avoid designing new shoes just because Crocs and Ugg Boots are already on the market.